Apotex has been a trusted name in the Canadian pharmaceutical community for over 40 years, providing patients with increased access to quality, affordable medicines. As a global company, Apotex operates distinct lines of business, including Global Generics, which features over 300 prescription and OTC drugs in more than 4000 doses and formats. Additionally, Apotex Pharmachem develops over 200 active pharmaceutical ingredients (APIs) for major markets. The company also focuses on Apobiologix for biosimilars and complex molecule development and ApoPharma for innovative medicines. Apotex Inc. boasts a wide out-licensing portfolio of over 100 finished drug products.

Services include:
– Biologics
– Finished Dosage Forms
– Active Pharmaceutical Ingredients (APIs)
– Contract Manufacturing (CMO/CDMO)

Apotex is committed to enhancing the pharmaceutical landscape by delivering high-quality and accessible solutions across various sectors. For further information, please visit apotexpharmachem.com.